The effect of curcumin on the fatigue and muscle soreness

Phase 3

Recruiting

Conditions: Fatigue and muscle soreness.

Registration Number: IRCT20120718010324N72

Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Female

Target Recruitment: 74

Inclusion Criteria

Women with normal menopause
At least one year after amenorrhea
Sufficient literacy to complete the questionnaire or accompany a literate person in the family
Age minimum 40 years and maximum 60 years

Exclusion Criteria

Abuse of tobacco and alcohol
Use of herbal medicines
Occurrence of a stressful event (such as divorce, death of first-degree family members, diagnosis of incurable disease for a family member within the last three months, and loss of job)
Psychiatric or systemic disorders (such as cardiovascular, digestive, hepatic, blood, endocrine, and gallstones)
Taking any medication that affects hot flashes (clonidine, methyldopa, gabapentin, SSRIs, SNRIs, soy isoflavones), thyroid disease (as reported by women)
Taking antidepressants (such as serotonin and noradrenaline reuptake inhibitors, antihistamines, barbiturates, narcotics, diazepam, amphetamines, and cocaine)
History of allergy to turmeric or other drugs, allergy to certain foods and food dyes
Taking anticoagulants such as heparin, aspirin, clopidogrel, dipyridamole, warfarin, enoxaparin and ticlopidine.

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fatigue. Timepoint: At the beginning of the study and 8 weeks after the start of consumption. Method of measurement: Short questionnaire of the perimenopausal fatigue scale.;Muscle soreness. Timepoint: At the beginning of the study and 8 weeks after the start of consumption. Method of measurement: MUSCULOSKELETAL HEALTH QUESTIONNAIRE (MSK-HQ).

Secondary Outcome Measures

Name	Time	Method
Depression. Timepoint: At the beginning of the study and 8 weeks after the start of consumption. Method of measurement: Beck Depression Inventory (BDI-13).